MolGen, a global solutions provider of innovative DNA/RNA extraction and lab automation, has appointed Hayden Jeffreys as Global Vice President of Sales & Marketing.
Agilent Technologies will sell Resolution Bioscience to Exact Sciences, a leading provider of cancer screening and diagnostic tests. Financial terms of the agreement were not disclosed. Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. Agilent acquired the company in 2021.
SMi Systems has secured a patent from the UK Intellectual Property Office (IPO) for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform. The patented technology consists of highly specialised optics that allow SMi to view single molecules at unprecedented resolution. When combined with the company’s uniquely designed consumables and deep learning techniques, the […]
SSI Strategy will acquire NDA Group, a leading regulatory affairs and drug development consultancy. Financial terms of the transaction were not disclosed.
Navigo Proteins and Nostrum Biodiscovery have joined forces to co-develop a new cutting-edge pipeline of de novo designed ubiquitin-based Affilin ligands, expanding Navigo’s proprietary Affilin technology.
For years, capturing detailed three-dimensional images of complex biological specimens has posed a major challenge due to their intricate composition and the multiple scattering of light. A game-changing moment has arrived, as scientists from the MIT Laser Biomedical Research Center and the Chinese University of Hong Kong have introduced an innovative method called speckle diffraction […]
A powerful new antibiotic, isolated from bacteria that could not be studied before, seems capable of combatting harmful bacteria and multi-drug resistant ‘superbugs’. Named Clovibactin, the antibiotic appears to kill bacteria in an unusual way, making it more difficult for bacteria to develop resistance against it.
The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Pfizer Europe’s Abrysvo ( EMA opinion on Abrysvo: https://bit.ly/45jVL7Z ), a vaccine to protect against disease caused by the respiratory syncytial virus (RSV). Abrysvo is the first RSV vaccine indicated for passive immunisation of infants from birth through […]
UK Health Security Agency opens advanced Vaccine Development and Evaluation Centre
TVM Capital Life Science, a leading international venture capital firm focused on investments in life sciences innovation, together with specialty pharma company, Tillotts Pharma, will jointly invest up to US$28 million in the newly formed U.S.-based biotechnology company, Mage Biologics. TVM will invest with its fund TVM Life Science Innovation II SCSp (TVM LSI II) […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
